▶ 調査レポート

世界のバイオ契約開発&製造組織(CDMO)市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のバイオ契約開発&製造組織(CDMO)市場規模・現状・予測(2021年-2027年) / Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size, Status and Forecast 2021-2027 / QFJ1-3900資料のイメージです。• レポートコード:QFJ1-3900
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、バイオ契約開発&製造組織(CDMO)の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(API開発、製造、薬物送達)、用途別市場規模(製薬会社、バイオテクノロジー会社、ジェネリック会社)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・バイオ契約開発&製造組織(CDMO)の市場動向
・企業の競争状況、市場シェア
・バイオ契約開発&製造組織(CDMO)の種類別市場規模と予測2016-2027(API開発、製造、薬物送達)
・バイオ契約開発&製造組織(CDMO)の用途別市場規模と予測2016-2027(製薬会社、バイオテクノロジー会社、ジェネリック会社)
・バイオ契約開発&製造組織(CDMO)の北米市場規模2016-2027(アメリカ、カナダ)
・バイオ契約開発&製造組織(CDMO)の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・バイオ契約開発&製造組織(CDMO)のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・バイオ契約開発&製造組織(CDMO)の中南米市場規模2016-2027(メキシコ、ブラジル)
・バイオ契約開発&製造組織(CDMO)の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Lonza、Boehringer ‎Ingelheim、Celltrion、Fujifilm、Selexis、Ology Bio、Ardena、Catalent、AGC、Amgen)
・結論

A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.

Market Analysis and Insights: Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market
The global Bio Contract Development and Manufacturing Organizations (CDMOs) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bio Contract Development and Manufacturing Organizations (CDMOs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bio Contract Development and Manufacturing Organizations (CDMOs) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bio Contract Development and Manufacturing Organizations (CDMOs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bio Contract Development and Manufacturing Organizations (CDMOs) market.

Global Bio Contract Development and Manufacturing Organizations (CDMOs) Scope and Market Size
Bio Contract Development and Manufacturing Organizations (CDMOs) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bio Contract Development and Manufacturing Organizations (CDMOs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
API Development
Manufacturing
Drug Delivery

Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Lonza
Boehringer ‎Ingelheim
Celltrion
Fujifilm
Selexis
Ology Bio
Ardena
Catalent
AGC
Amgen

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 API Development
1.2.3 Manufacturing
1.2.4 Drug Delivery
1.3 Market by Application
1.3.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Generic Company
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Perspective (2016-2027)
2.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Growth Trends by Regions
2.2.1 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Historic Market Share by Regions (2016-2021)
2.2.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Regions (2022-2027)
2.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Industry Dynamic
2.3.1 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Trends
2.3.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Drivers
2.3.3 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Challenges
2.3.4 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Revenue
3.1.1 Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Revenue (2016-2021)
3.1.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Players (2016-2021)
3.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue
3.4 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Concentration Ratio
3.4.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue in 2020
3.5 Bio Contract Development and Manufacturing Organizations (CDMOs) Key Players Head office and Area Served
3.6 Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Product Solution and Service
3.7 Date of Enter into Bio Contract Development and Manufacturing Organizations (CDMOs) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bio Contract Development and Manufacturing Organizations (CDMOs) Breakdown Data by Type
4.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Historic Market Size by Type (2016-2021)
4.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Type (2022-2027)

5 Bio Contract Development and Manufacturing Organizations (CDMOs) Breakdown Data by Application
5.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Historic Market Size by Application (2016-2021)
5.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2016-2027)
6.2 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type
6.2.1 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021)
6.2.2 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027)
6.2.3 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2027)
6.3 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application
6.3.1 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021)
6.3.2 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027)
6.3.3 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2027)
6.4 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country
6.4.1 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021)
6.4.2 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2016-2027)
7.2 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type
7.2.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021)
7.2.2 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027)
7.2.3 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2027)
7.3 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application
7.3.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021)
7.3.2 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027)
7.3.3 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2027)
7.4 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country
7.4.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021)
7.4.2 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2016-2027)
8.2 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type
8.2.1 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2027)
8.3 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application
8.3.1 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2027)
8.4 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region
8.4.1 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2016-2027)
9.2 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type
9.2.1 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021)
9.2.2 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027)
9.2.3 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2027)
9.3 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application
9.3.1 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021)
9.3.2 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027)
9.3.3 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2027)
9.4 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country
9.4.1 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021)
9.4.2 Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (2016-2027)
10.2 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type
10.2.1 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2027)
10.3 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application
10.3.1 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2027)
10.4 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country
10.4.1 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.1.4 Lonza Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
11.1.5 Lonza Recent Development
11.2 Boehringer ‎Ingelheim
11.2.1 Boehringer ‎Ingelheim Company Details
11.2.2 Boehringer ‎Ingelheim Business Overview
11.2.3 Boehringer ‎Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.2.4 Boehringer ‎Ingelheim Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
11.2.5 Boehringer ‎Ingelheim Recent Development
11.3 Celltrion
11.3.1 Celltrion Company Details
11.3.2 Celltrion Business Overview
11.3.3 Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.3.4 Celltrion Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
11.3.5 Celltrion Recent Development
11.4 Fujifilm
11.4.1 Fujifilm Company Details
11.4.2 Fujifilm Business Overview
11.4.3 Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.4.4 Fujifilm Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
11.4.5 Fujifilm Recent Development
11.5 Selexis
11.5.1 Selexis Company Details
11.5.2 Selexis Business Overview
11.5.3 Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.5.4 Selexis Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
11.5.5 Selexis Recent Development
11.6 Ology Bio
11.6.1 Ology Bio Company Details
11.6.2 Ology Bio Business Overview
11.6.3 Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.6.4 Ology Bio Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
11.6.5 Ology Bio Recent Development
11.7 Ardena
11.7.1 Ardena Company Details
11.7.2 Ardena Business Overview
11.7.3 Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.7.4 Ardena Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
11.7.5 Ardena Recent Development
11.8 Catalent
11.8.1 Catalent Company Details
11.8.2 Catalent Business Overview
11.8.3 Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.8.4 Catalent Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
11.8.5 Catalent Recent Development
11.9 AGC
11.9.1 AGC Company Details
11.9.2 AGC Business Overview
11.9.3 AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.9.4 AGC Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
11.9.5 AGC Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Introduction
11.10.4 Amgen Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
11.10.5 Amgen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of API Development
Table 3. Key Players of Manufacturing
Table 4. Key Players of Drug Delivery
Table 5. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Regions (2016-2021)
Table 9. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Regions (2022-2027)
Table 11. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Trends
Table 12. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Drivers
Table 13. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Challenges
Table 14. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Restraints
Table 15. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Players (2016-2021)
Table 17. Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) as of 2020)
Table 18. Ranking of Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bio Contract Development and Manufacturing Organizations (CDMOs) Product Solution and Service
Table 22. Date of Enter into Bio Contract Development and Manufacturing Organizations (CDMOs) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Type (2016-2021)
Table 26. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Application (2016-2021)
Table 30. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Lonza Company Details
Table 63. Lonza Business Overview
Table 64. Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Product
Table 65. Lonza Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
Table 66. Lonza Recent Development
Table 67. Boehringer ‎Ingelheim Company Details
Table 68. Boehringer ‎Ingelheim Business Overview
Table 69. Boehringer ‎Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Product
Table 70. Boehringer ‎Ingelheim Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
Table 71. Boehringer ‎Ingelheim Recent Development
Table 72. Celltrion Company Details
Table 73. Celltrion Business Overview
Table 74. Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Product
Table 75. Celltrion Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
Table 76. Celltrion Recent Development
Table 77. Fujifilm Company Details
Table 78. Fujifilm Business Overview
Table 79. Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Product
Table 80. Fujifilm Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
Table 81. Fujifilm Recent Development
Table 82. Selexis Company Details
Table 83. Selexis Business Overview
Table 84. Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Product
Table 85. Selexis Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
Table 86. Selexis Recent Development
Table 87. Ology Bio Company Details
Table 88. Ology Bio Business Overview
Table 89. Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Product
Table 90. Ology Bio Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
Table 91. Ology Bio Recent Development
Table 92. Ardena Company Details
Table 93. Ardena Business Overview
Table 94. Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Product
Table 95. Ardena Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
Table 96. Ardena Recent Development
Table 97. Catalent Company Details
Table 98. Catalent Business Overview
Table 99. Catalent Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
Table 100. Catalent Recent Development
Table 101. AGC Company Details
Table 102. AGC Business Overview
Table 103. AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Product
Table 104. AGC Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
Table 105. AGC Recent Development
Table 106. Amgen Company Details
Table 107. Amgen Business Overview
Table 108. Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Product
Table 109. Amgen Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021) & (US$ Million)
Table 110. Amgen Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type: 2020 VS 2027
Figure 2. API Development Features
Figure 3. Manufacturing Features
Figure 4. Drug Delivery Features
Figure 5. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application: 2020 VS 2027
Figure 6. Pharmaceutical Company Case Studies
Figure 7. Biotechnology Company Case Studies
Figure 8. Generic Company Case Studies
Figure 9. Bio Contract Development and Manufacturing Organizations (CDMOs) Report Years Considered
Figure 10. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Regions: 2020 VS 2027
Figure 13. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Regions (2022-2027)
Figure 14. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Players in 2020
Figure 15. Global Top Bio Contract Development and Manufacturing Organizations (CDMOs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Contract Development and Manufacturing Organizations (CDMOs) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue in 2020
Figure 17. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Type (2016-2021)
Figure 18. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Type (2022-2027)
Figure 19. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2016-2027)
Figure 21. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2016-2027)
Figure 22. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Country (2016-2027)
Figure 23. United States Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2016-2027)
Figure 27. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2016-2027)
Figure 28. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Country (2016-2027)
Figure 29. Germany Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Region (2016-2027)
Figure 39. China Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2016-2027)
Figure 47. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2016-2027)
Figure 48. Latin America Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Country (2016-2027)
Figure 49. Mexico Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share by Country (2016-2027)
Figure 55. Turkey Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Lonza Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
Figure 59. Boehringer ‎Ingelheim Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
Figure 60. Celltrion Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
Figure 61. Fujifilm Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
Figure 62. Selexis Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
Figure 63. Ology Bio Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
Figure 64. Ardena Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
Figure 65. Catalent Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
Figure 66. AGC Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
Figure 67. Amgen Revenue Growth Rate in Bio Contract Development and Manufacturing Organizations (CDMOs) Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed